Panacos Pharmaceuticals, Inc.
PANC · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -36.6% | -72.9% | -21.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -21,237.8% | -14,416.9% | -3,807.2% | -878.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20,810.6% | -13,419% | -5,631.8% | -900.4% |
| EPS Diluted | -0.7 | -0.75 | -1.72 | -14.51 |
| % Growth | 6.7% | 56.4% | 88.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |